Yuan, Yue,
Han, Xuejie,
Zhao, Xinbo,
Zhang, Haiyu,
Vinograd, Asiia,
Bi, Xin,
Duan, Xiaoxu,
Cao, Yukai,
Gao, Qiang,
Song, Jia,
Sheng, Li,
Li, Yue (2024) -coding RNAs (lncRNAs), involve in the progress of multiple cardiovascular diseases. However, their
potentialLi, Xiang,
Yin, Lina,
Liao, Jing,
Yang, Jun,
Cai, Binhao,
Yu, Yiming,
Su, Sijia,
Du, Zhiteng,
Li, Xiaobo,
Zhou, Ying,
Chen, Pan,
Cho, Won-Jea,
Chattipakorn, Nipon,
Samorodov, Aleksandr V.,
Pavlov, Valentin N.,
Zhang, Fengzhi,
Liang, Guang,
Tang, Qidong (2023) pharmacodynamic and pharmacokinetic characteristics, which suggested that L26 could serve as a
potential agent
Galimova, E.F.,
Gromenko, I.D.,
Gilyazova, I.R.,
Gromenko, D.D.,
Galimov, K.Sh.,
Abdeeva, G.R.,
Gromenko, Yu.Yu.,
Khusnutdinova, E.K.,
Galimov, Sh.N. (2024) RNA molecules selected for the study not only demonstrated their
potential ability to be used as a diagnostic
Zhu, Weiwei,
Luo, Wu,
Han, Jibo,
Zhang, Qiuyan,
Ji, Lijun,
Samorodov, Aleksandr V.,
Pavlov, Valentin N.,
Zhuang, Zaishou,
Yang, Daona,
Yin, Lina,
Huang, Lijiang,
Liang, Guang (2023) the differential effects and
potential target of Sch B. ALI was induced by intratracheal administration of LPS
Jiang, HP,
Zhang, DZ,
Aleksandrovich, KD,
Ye, JY,
Wang, LX,
Chen, XF,
Gao, M,
Wang, XZ,
Yan, T,
Yang, H,
Lu, EZ,
Liu, WW,
Zhang, C,
Wu, JN,
Yao, PL,
Sun, ZY,
Rong, X,
Timofeevich, SA,
Mahmutovich, SS,
Zheng, ZX,
Chen, X,
Zhao, SG (2022) , and RRM2 may be a
potential therapeutic target and a prognosis and predictive biomarker in GBM patients.
Baran, M.F.,
Keskin, C.,
Baran, Ay¸se,
Hatipo, A.,
Yildiztekin, M.,
Küçükaydin, S.,
Kurt, K.,
Ho, H.,
Rahman Sarker, Md. Moklesur,
Sufianov, A.,
Beylerli, O.,
Khalilov, R.,
Eftekhari, A. (2023) the biosynthesized nanoparticles. The
crystal average size and zeta
potential of AC-AgNPs with predominantly